Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Daiken Medical CoTSE:7775 +0.24%62 EV-to-FCF is 48.81 as of Jul. 30, 2026, which is 159% above its 10-year median of 18.82. GuruFocus rates TSE:7775 with a GF Score™ of 62/100 and a GF Value™ of 円541.84 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 417 Medical Devices & Instruments companies, Daiken Medical Co ranks worse than 76.98% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Daiken Medical Co's Enterprise Value is 円11,710 Mil.
Daiken Medical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was 円240 Mil. Therefore, Daiken Medical Co's EV-to-FCF for today is 48.81.
The historical rank and industry rank for Daiken Medical Co's EV-to-FCF or its related term are showing as below:
TSE:7775'
s EV-to-FCF Range Over the Past 10 Years
Min: -1277.89 Med: 18.82 Max: 62.78
Current: 48.93
During the past 13 years, the highest EV-to-FCF of Daiken Medical Co was 62.78. The lowest was -1277.89. And the median was 18.82.
TSE:7775's EV-to-FCF is ranked worse than 76.98% of 417
companies
in the Medical Devices & Instruments industry
Industry Median: 23.7
vs TSE:7775: 48.93
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Daiken Medical Co (TSE:7775) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Daiken Medical Co's PE Ratio (TTM) for today is calculated as:
Daiken Medical Co's share price for today is 円426.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Daiken Medical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was 円32.118.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Daiken Medical Co EV-to-FCF Related Terms
Daiken Medical Co EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Daiken Medical Co's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Daiken Medical Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Daiken Medical Co EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Daiken Medical Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Daiken Medical Co's EV-to-FCF falls into.
Daiken Medical Co's current Enterprise Value is 円11,710 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Daiken Medical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was 円240 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Daiken Medical Co (TSE:7775) has a EV-to-FCF of 48.81 as of Jul. 30, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Daiken Medical Co and its competitors. This is 159% above median its historical median of 18.82. According to the industry distribution chart, Daiken Medical Co ranks #321 out of 417 companies in the Medical Devices & Instruments industry, placing it in the top 77%.
Is Daiken Medical Co's EV-to-FCF too high?
Daiken Medical Co's current EV-to-FCF of 48.81 is 159% above median its 10-year median of 18.82. The Medical Devices & Instruments industry median EV-to-FCF is 23.70. Daiken Medical Co's value of 48.81 is 105.9% above this industry median. Based on the distribution chart, Daiken Medical Co ranks #321 out of 417 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Daiken Medical Co has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Daiken Medical Co's EV-to-FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Daiken Medical Co ranks #321 out of 417 companies for EV-to-FCF. This places Daiken Medical Co in the lower half of its industry. The industry median EV-to-FCF is 23.70. Daiken Medical Co's value of 48.81 is 105.9% above this benchmark. While the company's 10-year median is 18.82 vs. the industry median of 23.70, Daiken Medical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.70, based on 417 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Daiken Medical Co's current EV-to-FCF of 48.81 is 105.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Daiken Medical Co and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Daiken Medical Co's current EV-to-FCF is 48.81, which is 159% above median its own 10-year median of 18.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Daiken Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Daiken Medical Co (TSE:7775) is currently considered Modestly Undervalued. The stock's GF Value™ is 円541.84, compared to a current price of 円426.00 — trading 21.4% below its estimated fair value. The current EV-to-FCF is 48.81, which is 159% above median its 10-year median of 18.82 and 105.9% above the Medical Devices & Instruments industry median of 23.70. Daiken Medical Co's overall GF Score™ is 62/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Daiken Medical Co (TSE:7775), the current EV-to-FCF is 48.81 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Daiken Medical Co (TSE:7775) Overvalued in 2026?
Based on GuruFocus' analysis, Daiken Medical Co stock appears to be undervalued.
The current stock price of 円426.00 is trading 21.4% below its estimated GF Value™ of 円541.84.
GuruFocus considers Daiken Medical Co to be Modestly Undervalued.
Key valuation signals for TSE:7775:
EV-to-FCF: 48.81 (159% above median its 10-year median of 18.82)
GF Value™: 円541.84 vs. price of 円426.00 (21.4% below fair value)
Industry Position: 105.9% above the Medical Devices & Instruments median (#321 of 417)
No single metric tells the full story. See the TSE:7775 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Daiken Medical Co Ltd manufactures and sells medical equipment. The product line includes - Coopdech syrinjector, Coopdech Syrinjector PCA device, Coopdech Balloonjector, Coopdech Endobronchial blocker tube, Coopdech double-lumen endobronchial tube, Fit fix suction container system, Wet disinfectant mat, and others.
62GF Score
Get the complete analysis for TSE:7775
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7775 has been successfully added to your 
